HomeCT9 • FRA
add
Cardiol Therapeutics Inc
Previous close
€1.09
Day range
€1.14 - €1.25
Year range
€0.60 - €1.37
Market cap
221.40M CAD
Avg Volume
254.00
P/E ratio
-
Dividend yield
-
Primary exchange
TSE
In the news
Financials
Income Statement
Revenue
Net income
| (CAD) | Dec 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 8.03M | -19.61% |
Net income | -7.21M | 11.81% |
Net profit margin | — | — |
Earnings per share | -0.07 | — |
EBITDA | -7.96M | 20.09% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (CAD) | Dec 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 21.42M | -29.97% |
Total assets | 23.62M | -25.87% |
Total liabilities | 5.74M | -19.52% |
Total equity | 17.88M | — |
Shares outstanding | 97.94M | — |
Price to book | 6.08 | — |
Return on assets | -109.81% | — |
Return on capital | -144.97% | — |
Cash Flow
Net change in cash
| (CAD) | Dec 2025info | Y/Y change |
|---|---|---|
Net income | -7.21M | 11.81% |
Cash from operations | -5.23M | 6.58% |
Cash from investing | -3.09K | 49.86% |
Cash from financing | 15.55M | -16.82% |
Net change in cash | 9.79M | -33.35% |
Free cash flow | -11.22M | -316.99% |
About
CEO
Founded
2017
Headquarters
Website
Employees
18
